## JBL: Jabil Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.4% in lower entry zone (3.0-6.0%), top 4% cross-sectional ranking. Short-term MRS_5 (2.9%) confirms momentum alignment. Strong momentum (+3.5% 5-day acceleration). Outperforming sector by 3.2%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($215.72)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Anousheh Ansari, Jabil Inc director, sells $337k in stock**
- Source: Investing.com | 20251223T000841 | Bullish | Relevance: 100%
- Anousheh Ansari, a director at Jabil Inc (NYSE:JBL), sold 1,500 shares of common stock for $337,500 on December 19, 2025, according to a recent Form 4 filing. This sale occurred amidst positive financial news for Jabil, including strong Q1 2026 results that surpassed analyst estimates and raised price targets from UBS, Goldman Sachs, and BofA Securities. These developments highlight a positive outlook for Jabil's financial health and growth prospects.

**2. Jabil Inc: executive chairman Mondello sells $11.2 million in stock**
- Source: Investing.com | 20251223T000827 | Bullish | Relevance: 100%
- Jabil Inc.'s Executive Chairman, Mark T. Mondello, sold 50,000 shares of common stock for $11.2 million. This transaction occurred as Jabil's stock trades near its 52-week high, having delivered a 58.74% return over the past year. Despite the insider selling, analysts maintain positive sentiment, with UBS and BofA Securities raising their price targets following Jabil's strong Q1 fiscal 2026 results which exceeded expectations.

**3. Jabil sells two St. Petersburg buildings for $25M in leaseback deal**
- Source: The Business Journals | 20251222T182727 | Neutral | Relevance: 100%
- Jabil, an electronics manufacturer, has sold two St. Petersburg buildings for $25 million in a leaseback deal. This move comes as the company plans to invest heavily in a new manufacturing facility in North Carolina. Jabil will continue to occupy the buildings, securing their operations in St. Petersburg while expanding elsewhere.

**4. Jabil opens medical device lab to foster innovation**
- Source: St Pete Catalyst | 20251222T173906 | Bullish | Relevance: 100%
- Jabil Inc. has opened a new Advanced Catheter Development Lab at its St. Petersburg headquarters, aiming to position the city as a center for innovation in minimally invasive medical devices. This lab, developed in collaboration with the University of Florida and the University of South Florida, offers comprehensive design, development, prototyping, and testing capabilities to help researchers and manufacturers meet the growing demand for these medical products. The initiative is set to foster new industry innovations and support academic pipelines for improved health outcomes.

**5. The Rise of Jabil (JBL): From Circuit Boards to AI Infrastructure Powerhouse**
- Source: FinancialContent | 20251222T150841 | Bullish | Relevance: 100%
- Jabil Inc. (NYSE: JBL) has transformed from a traditional contract manufacturer into a key player in global AI infrastructure and specialized healthcare ecosystems. This strategic pivot, marked by the sale of its Mobility business, has resulted in Jabil becoming a top performer in the S&P 500, with robust financial results driven by high-margin segments like AI and data centers. The company's focus on capital efficiency and engineering excellence under CEO Michael Dastoor positions it strongly in the evolving industrial technology sector.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | JP Morgan | $270 | $260 | +4% |
| 2025-12-18 | Barclays | $283 | $267 | +6% |
| 2025-12-18 | UBS | $244 | $239 | +2% |
| 2025-12-10 | B of A Securiti | $262 | $255 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | JP Morgan | main | Overweight |
| 2025-12-18 | Barclays | main | Overweight |
| 2025-12-18 | UBS | main | Neutral |
| 2025-12-10 | B of A Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.00M) |
| Sells | 50 ($12.50M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (-0.1%)
- Blackrock Inc.: 9.0% (+2.1%)
- Texas Yale Capital C: 6.0% (-0.1%)
- State Street Corpora: 4.9% (+0.7%)
- Wellington Managemen: 4.1% (-30.7%)

### Key Risks

1. Heavy insider selling: $13M sold (50 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 4 raises (avg +4%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +3.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.91 indicates undervaluation relative to growth. Quality metrics strong (ROE 48%). Insider selling cluster ($12.5M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $25.1B |
| Beta | 1.26 |
| 52W Range | $108.66 - $237.14 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.91 |
| Forward P/E | 17.3 |
| Current P/E | 20.2 |
| YoY Growth | 16.5% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -0.1% to 3.4% (+3.5% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 96th percentile. MRS_5 at 2.9% confirms short-term momentum alignment. Outperforming sector by 3.2pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.02), confirming momentum. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.37% (CS: 96) | Strong |
| RSI_14 | 64.7 | Neutral |
| MACD Histogram | 1.02 | Bullish |
| vs SMA20 | 1.069x | Above |
| vs SMA50 | 1.104x | Above |
| vs SMA200 | 1.219x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $235.04
- **Stop Loss:** $215.72 (8.2% risk)
- **Target:** $264.02 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 62
- **Position Value:** $14,572.48
- **Portfolio %:** 14.57%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.73 | $2.85 | +4.4% |
| 2025Q3 | $2.95 | $3.29 | +11.7% |
| 2025Q2 | $2.32 | $2.55 | +9.8% |
| 2025Q1 | $1.83 | $1.94 | +6.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*